Metamark Genetics, Inc. Names Dr. Peter Maimonis As Senior Vice President And Chief Science Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metamark Genetics, Inc. ("Metamark" or the "Company"), a leader in commercializing high value urologic oncology products, announced today that Peter Maimonis, Ph.D., has joined Metamark's leadership team as Senior Vice President and Chief Science Officer, effective October 7, 2015.

Suggested Articles

The inclusion of Kupffer cells in in vitro hepatic cultures provides researchers with advanced tools for disease modeling and drug discovery.

A delay to Moderna's phase 3 COVID-19 study is part of a trend of tensions in the biotech’s relationship with the U.S. government, Reuters reported.

GlaxoSmithKline is continuing its strategy of giving out access to its vaccine platform as it adds Medicago to its growing partners list.